What is the recommended dose of magnesium sulphate (MgSO4) for various medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Magnesium Sulfate Dosing by Clinical Indication

For acute severe asthma in adults, administer 2 g IV magnesium sulfate over 20 minutes as adjunctive therapy when patients remain severe after 1 hour of intensive standard treatment; for preeclampsia/eclampsia, use a loading dose of 4-5 g IV over 20-30 minutes followed by 1-2 g/hour maintenance infusion. 1, 2

Acute Severe Asthma

Adult Dosing

  • Administer 2 g IV magnesium sulfate diluted to 20% or less concentration over 20 minutes for patients with severe exacerbations (FEV1 <30% predicted) who have not responded adequately to standard therapy (oxygen, nebulized short-acting beta-agonists, and IV corticosteroids) 1, 3, 2
  • The greatest benefit occurs in patients with FEV1 <20% predicted, where magnesium significantly improves lung function and reduces pulse rate at 4 hours 4
  • A Cochrane meta-analysis demonstrated that IV magnesium reduces hospital admissions by approximately 7 per 100 patients treated (OR 0.75,95% CI 0.60-0.92) and improves spirometric indices 5

Pediatric Dosing

  • Administer 25-75 mg/kg IV (maximum 2 g) over 20 minutes for children with life-threatening asthma exacerbations or those remaining severe after 1 hour of intensive conventional treatment 6
  • Monitor for hypotension during administration, as rapid infusion may cause hypotension and bradycardia 6
  • Have calcium chloride immediately available to counteract potential magnesium toxicity 1, 6

Important Considerations for Asthma

  • Magnesium sulfate should be used as an adjunct to standard therapy, not as a replacement for inhaled beta-agonists, anticholinergics, and systemic corticosteroids 6, 3
  • The mechanism involves bronchial smooth muscle relaxation independent of serum magnesium level, providing complementary bronchodilation 6, 3
  • Common side effects include flushing, light-headedness, and hypotension, but the safety profile is generally favorable 3, 5

Preeclampsia/Eclampsia

Loading Dose

  • Administer 4-5 g IV magnesium sulfate in 250 mL of 5% dextrose or 0.9% normal saline infused over 20-30 minutes 1, 2
  • Alternatively, give 4 g IV by diluting the 50% solution to 10-20% concentration and inject over 3-4 minutes 2
  • Simultaneously, IM doses of up to 10 g (5 g in each buttock using undiluted 50% solution) may be given for total initial dose of 10-14 g 2

Maintenance Infusion

  • Continue with 1-2 g/hour by constant IV infusion after the loading dose 1, 2
  • Alternatively, inject 4-5 g IM into alternate buttocks every 4 hours as needed, depending on presence of patellar reflex and adequate respiratory function 2
  • Target serum magnesium level of 6 mg/100 mL is considered optimal for seizure control 2

Duration and Safety

  • Continue magnesium sulfate for 24 hours postpartum as the standard recommendation 1
  • Alternative approach: May discontinue after administering at least 8 g predelivery in select populations, though this requires consideration of local postpartum eclampsia incidence 1
  • Do not exceed total daily dose of 30-40 g in 24 hours 2
  • In severe renal insufficiency, maximum dosage is 20 g/48 hours with frequent serum magnesium monitoring 2
  • Do not continue beyond 5-7 days in pregnancy as continuous maternal administration can cause fetal abnormalities 2

Other Indications

Torsades de Pointes

  • Administer 1-2 g IV over 15 minutes for polymorphic VT associated with QT prolongation, regardless of serum magnesium level 1
  • Have calcium immediately available to counteract magnesium toxicity 1

Magnesium Deficiency

  • Mild deficiency: 1 g (8.12 mEq) IM every 6 hours for 4 doses (total 32.5 mEq/24 hours) 2
  • Severe hypomagnesemia: Up to 250 mg/kg (approximately 2 mEq/kg) IM within 4 hours, or 5 g (40 mEq) added to 1 L IV fluid infused over 3 hours 2
  • For acute hypomagnesemia: 1-2 g IV over 15 minutes, followed by maintenance infusion of 1 g/hour for 24 hours if needed 1

Other Uses

  • Barium poisoning: 1-2 g IV 2
  • Seizures (epilepsy, glomerulonephritis, hypothyroidism): 1 g IM or IV 2
  • Paroxysmal atrial tachycardia: 3-4 g IV over 30 seconds with extreme caution, only if simpler measures have failed and no myocardial damage 2
  • Cerebral edema: 2.5 g IV 2

Critical Administration Guidelines

Dilution Requirements

  • Solutions for IV infusion must be diluted to 20% or less concentration prior to administration 2
  • Common diluents are 5% dextrose or 0.9% normal saline 2
  • For IM injection in children, dilute to 20% or less concentration (undiluted 50% solution appropriate only for adults) 2

Rate of Administration

  • Do not exceed 150 mg/minute IV (1.5 mL of 10% concentration) except in severe eclampsia with seizures 2
  • IM administration of undiluted 50% solution produces therapeutic levels in 60 minutes, whereas IV provides therapeutic levels almost immediately 2

Monitoring Requirements

  • Monitor patellar reflex, respiratory function, and urine output during therapy 2
  • Obtain frequent serum magnesium concentrations in renal insufficiency 2
  • Observe for hypotension, bradycardia, flushing, and respiratory depression 1, 6, 5

Common Pitfalls

  • Do not use magnesium as monotherapy for asthma—it must be combined with standard bronchodilators and corticosteroids 6, 3
  • Avoid rapid IV infusion as this increases risk of hypotension and bradycardia 6
  • Do not exceed renal excretory capacity in deficiency states—adjust dose in renal insufficiency 2
  • Be aware of drug interactions: Magnesium may reduce antibiotic activity of streptomycin, tetracycline, and tobramycin when given together 2
  • Nebulized magnesium is less effective than IV for acute asthma, though it may provide modest additional benefit as adjunctive therapy 6, 3, 7, 8

References

Guideline

Magnesium Sulfate Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Role of Magnesium Sulfate in Treating Severe Asthma Exacerbations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Magnesium Sulfate Dosing in Pediatric Asthma Exacerbation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.